NeuroScientific widens chronic bowel disease stem cell therapy program

NeuroScientific Biopharmaceuticals has medicated a fourth fistulising Crohn’s disease patient with its unique “StemSmart” stem-cell therapy, in a key step forward for the company’s game-changing treatment of the debilitating bowel condition.

Approvals have already been secured to provide…